Follow
Abhishek Saxena Ph.D
Abhishek Saxena Ph.D
Group Leader, Shenzhen Bay Laboratory
Verified email at szbl.ac.cn - Homepage
Title
Cited by
Cited by
Year
Advances in therapeutic Fc engineering - modulation of IgG associated effector functions and serum half-life
A Saxena, D Wu
Frontiers in Immunology, 7:580, 2016
1432016
Fc Engineering for developing therapeutic bispecific antibodies and novel scaffolds
H Liu, A Saxena, SS Sidhu, D Wu
Frontiers in Immunology, 8:38, 2017
1282017
IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients
I Koneczny, JAA Stevens, A De Rosa, S Huda, M Huijbers, A Saxena
Journal of Autoimmunity 77, 104-115, 2017
1122017
IL‐17‐producing CD4+ T cells contribute to the loss of B‐cell tolerance in experimental autoimmune myasthenia gravis
H Schaffert, A Pelz, A Saxena, M Losen, A Meisel, A Thiel, S Kohler
European journal of immunology 45 (5), 1339-1347, 2015
772015
Proteasome inhibition with bortezomib depletes plasma cells and specific autoantibody production in primary thymic cell cultures from early-onset myasthenia gravis patients
AM Gomez, N Willcox, K Vrolix, J Hummel, G Nogales-Gadea, A Saxena, ...
The Journal of Immunology 193 (3), 1055-1063, 2014
502014
Global HIV-1 molecular epidemiology with special reference to genetic analysis of HIV-1 subtypes circulating in North India: Functional and pathogenic implications of genetic …
U Neogi, V Sood, S Banerjee, N Ghosh, S Verma, S Samrat, Y Sharma, ...
Indian journal of experimental biology 47 (6), 424, 2009
272009
Characterization of the thymus in Lrp4 myasthenia gravis: Four cases
I Koneczny, D Rennspiess, F Marcuse, N Dankerlui, MA Hamid, ...
Autoimmunity Reviews 18 (1), 50-55, 2019
212019
Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient
A Saxena, J Stevens, H Cetin, I Koneczny, R Webster, K Lazaridis, ...
Scientific reports 7 (1), 14426, 2017
192017
Neutralizing antibodies to SARS‐CoV‐2 selected from a human antibody library constructed decades ago
M Qiang, P Ma, Y Li, H Liu, A Harding, C Min, F Wang, L Liu, M Yuan, Q Ji, ...
Advanced Science 9 (1), 2102181, 2022
17*2022
Rapid assessment of binding affinity of SARS-COV-2 spike protein to the human angiotensin-converting enzyme 2 receptor and to neutralizing biomolecules based on computer …
D Buratto, A Saxena, Q Ji, G Yang, S Pantano, F Zonta
Frontiers in Immunology 12, 730099, 2021
152021
Alpha7 acetylcholine receptor autoantibodies are rare in sera of patients diagnosed with schizophrenia or bipolar disorder
C Hoffmann, J Stevens, S Zong, D van Kruining, A Saxena, Cİ Küçükali, ...
Plos one 13 (12), e0208412, 2018
122018
Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
G Nogales-Gadea, A Saxena, C Hoffmann, J Hounjet, D Coenen, ...
JoVE (Journal of Visualized Experiments), e52830, 2015
92015
Fc engineering: Tailored synthetic human IgG1-Fc repertoire for high-affinity interaction with FcRn at pH 6.0
A Saxena, B Bai, SC Hou, L Jiang, T Ying, S Miersch, SS Sidhu, D Wu
Antibody Engineering: Methods and Protocols, 399-417, 2018
12018
State-of-the-art preclinical evaluation of COVID-19 vaccine candidates
D Ghosh, B Bai, Q Ji, S Palliyil, G Yang, A Kumar, A Saxena
Exploration of Immunology 1, 440-460, 2021
2021
Physiology and Pathology of Multidrug-Resistant Bacteria: Phage-Related Therapy
L Jiang, A Saxena, D Wu
Physiology and Pathology of Immunology, 2017
2017
Anti-fungal antibody molecules and uses thereof
AJR Porter, M Lenardon, A Saxena
WO Patent WO2014174293A1, 2014
2014
The system can't perform the operation now. Try again later.
Articles 1–16